Berirab P 300 IU
$70.59
$59.95
Berirab P 300 IU is a vital rabies post-exposure prophylaxis (PEP) injection designed to safeguard individuals who may have been exposed to the rabies virus through bites, scratches, or contact with the saliva of infected animals. This effective vaccine contains human rabies immunoglobulin sourced from carefully screened blood plasma donors, providing essential antibodies to help prevent the onset of rabies. It is crucial to administer Berirab P promptly following potential exposure to ensure maximum efficacy in protecting against this life-threatening disease. Individuals receiving this treatment should be aware of potential side effects, such as allergic reactions, and should consult with a healthcare professional if they experience any unusual symptoms post-injection. While Berirab P is a critical component in rabies prevention, it is important to follow it up with a rabies vaccination schedule as recommended by your doctor. Always keep in mind that timely intervention is key in cases of suspected rabies exposure, so seeking medical advice immediately is essential. Overall, Berirab P 300 IU serves as a key player in the prevention of rabies, ensuring peace of mind for those at risk.
मात्रा
Active Pharmaceutical Ingredient
Uses
• Berirab p 300 iu is primarily utilized for the prevention of rabies infection following potential exposure. This includes situations where an individual has been bitten or scratched by an animal that may carry the rabies virus. The timely administration of Berirab p 300 iu can help the body mount an effective immune response. It is crucial in high-risk scenarios to ensure adequate protection.
• In cases of potential rabies exposure, Berirab p 300 iu plays a vital role in stimulating the immune system. This medication aids in the production of specific antibodies that are essential for neutralizing the rabies virus. By enhancing the body's defense mechanisms, Berirab p 300 iu contributes to safeguarding individuals from the severe consequences of rabies infection. Quick intervention with this treatment is key to effective prevention.
• Berirab p 300 iu is often recommended for individuals who have received a rabies exposure risk assessment. Health professionals may prescribe this medication to those who have experienced animal bites, especially from wild animals. The use of Berirab p 300 iu in conjunction with other preventive measures is critical in high-risk environments. It ensures that the body is prepared to combat the virus before symptoms develop.
• The administration of Berirab p 300 iu is a standard practice in post-exposure prophylaxis for rabies. This medication is designed to provide immediate protection by working alongside the body’s immune response. In emergency settings, Berirab p 300 iu is essential for individuals who may have been exposed to rabies. Its timely use can significantly reduce the risk of the virus taking hold.
Benefits
Berirab P 300 IU gives intravenous safety in opposition to rabies. It is specifically recommended for individuals who have been exposed to the rabies virus, such as through a bite or scratch from an infected animal. On the other hand, Human Rabies Immunoglobulin is prescribed in similar cases to ensure effective prevention and treatment.
Anti-rabies Vaccine Berirab has elevated levels of rabies antibodies that effectively neutralize the virus and prevent its transmission to humans. In addition, Berirab P 300 IU has the potential to reduce the required doses of rabies vaccine, providing a beneficial alternative for individuals who are unable to complete the full vaccination series.
Giving Berirab P Injection immediately after exposure to the rabies virus can greatly improve the chances of survival. This is crucial because rabies is a fatal disease that can be prevented with the help of Berirab P 300 IU. By taking immediate action and using Berirab P Injection, the risk of dying from rabies can be effectively reduced.
Side Effects
As with all medicines, Berirab P 300 IU may have side effects that do not require medical attention and that will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.
Most Common Side Effects
• Arm pain after vaccination
• Fever
• Chills
Common Side Effects
• Pain
• Swelling
• Warmth
• Sudden shortness of breath
• Chest pain
• Numbness
• Weakness on one side
• Difficulty speaking
• Confusion
How To Use
The injection of Berirab P 300 IU into a muscle is carried out by your doctor or nurse. The specific dosage and route of administration of Berirab P Injection will be determined based on factors such as the patient's clinical condition, age, and medical history. It is important to note that Human Rabies Immunoglobulin should not be self-administered and should only be taken under the guidance of a healthcare professional. Ideally, Berirab P 300 IU 2 ml Prefilled Syringe should be given as soon as possible within the first 24 hours after exposure to the virus. One dose of Berirab P 300 IU is injected directly into the wound or exposed area, and the remaining dose is injected into the muscle.
Safety Advice
• Alcohol: Drinking alcohol while consuming Berirab P 300 IU is generally discouraged as it can potentially heighten the chances of liver damage. It is advisable to either abstain from alcohol or restrict your alcohol intake when using any medication.
• Kidney: Berirab P 300 IU is safe to use in patients with kidney disease. No dose adjustment of Berirab P 300 IU is recommended. If you experience any side effects, please consult your doctor.
• Breastfeeding: The excretion of this Berirab P Injection in human milk is still unknown. Therefore, it is recommended to exercise caution when administering Berirab P 300 IU to a nursing mother. If you are currently breastfeeding and taking Berirab P Injection, it is essential to discuss with your doctor the potential risks and benefits of continuing to breastfeed. Your doctor will assist you in making the most suitable decision for the health of both you and your baby.
• Liver: Berirab P Injection is safe to use in patients with liver disease. No dose adjustment of Anti-rabies Vaccine Berirab is recommended. If you experience any side effects, please consult your doctor.
• Pregnancy: The effects of Human Rabies Immunoglobulin on animal reproduction have not been studied. It is uncertain whether Berirab P 300 IU can harm the fetus or affect reproductive ability when given to pregnant women. The use of Berirab P 300 IU in pregnant women should be limited to cases where it is clearly necessary.
• Driving: The effect of Berirab P 300 IU 2 ml Prefilled Syringe on driving skills is still unknown. Should any signs of impaired focus and delayed reaction arise, it is recommended to avoid driving a vehicle.